Two Sigma Securities »

Xilio Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $27k 32k 0.84
2024-09-30 $35k 44k 0.79
2024-06-30 $13k 13k 0.95

More positions owned by Two Sigma Securities

Ishares Core Msci Emkt (IEMG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cme (CME)
Fox Corp Cl A Com (FOXA)
Home Depot (HD)
Ishares Tr Broad Usd High (USHY)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Capital One Financial (COF)

View all positions for Two Sigma Securities

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Morgan Stanley
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments

View all funds holding Xilio Therapeutics